Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 23:59:59 | |||
| 57.10 EUR | +0.35% |
|
57.10 | 0.00% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.92B 3.33B 2.69B 2.5B 4.74B 318B 4.81B 32.2B 12.53B 156B 12.52B 12.25B 541B | P/E 2026 * |
21.8x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.89B 3.3B 2.66B 2.47B 4.7B 315B 4.76B 31.89B 12.41B 155B 12.4B 12.13B 536B | EV / Sales 2026 * |
3.74x | EV / Sales 2027 * | 3.16x |
| Free-Float |
31.63% | Yield 2026 * |
1.71% | Yield 2027 * | 1.97% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | +0.35% | ||
| 1 week | -2.56% | ||
| Current month | -1.30% | ||
| 1 month | -2.89% | ||
| 3 months | -30.91% | ||
| 6 months | -12.02% | ||
| Current year | -10.08% |
| 1 week | 56 | 58.85 | |
| 1 month | 56 | 59.7 | |
| Current year | 56 | 86.7 | |
| 1 year | 51.65 | 86.7 | |
| 3 years | 37.96 | 94.8 | |
| 5 years | 35.2 | 94.8 | |
| 10 years | 10.8 | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/04/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 15/03/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.35% | -2.56% | +1.60% | +39.27% | 3.33B | ||
| -1.14% | -2.43% | +55.27% | +159.07% | 1,082B | ||
| -1.41% | +0.32% | +67.02% | +60.48% | 633B | ||
| -2.42% | +0.18% | +35.78% | +85.62% | 461B | ||
| -2.79% | +1.37% | +31.00% | +23.05% | 338B | ||
| -2.46% | -1.52% | +36.42% | +32.77% | 299B | ||
| -2.20% | -0.93% | +27.50% | +40.62% | 291B | ||
| -1.77% | +0.99% | -28.85% | -41.41% | 222B | ||
| -2.06% | +1.63% | +25.09% | +64.34% | 202B | ||
| -1.26% | +2.60% | +15.95% | +70.00% | 163B | ||
| Average | -1.65% | +3.72% | +26.68% | +53.38% | 369.57B | |
| Weighted average by Cap. | -1.65% | +5.42% | +40.44% | +79.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 884M 713M 662M 1.26B 84.3B 1.27B 8.53B 3.32B 41.38B 3.32B 3.25B 143B | 898M 1.03B 827M 768M 1.46B 97.83B 1.48B 9.9B 3.85B 48.02B 3.85B 3.77B 166B |
| Net income | 133M 152M 122M 114M 216M 14.48B 219M 1.47B 571M 7.11B 570M 558M 24.65B | 178M 203M 164M 152M 288M 19.34B 292M 1.96B 762M 9.5B 762M 745M 32.92B |
| Net Debt | -27.87M -31.82M -25.67M -23.83M -45.25M -3.04B -45.86M -307M -120M -1.49B -120M -117M -5.17B | -85.9M -98.08M -79.12M -73.44M -139M -9.36B -141M -947M -369M -4.59B -368M -360M -15.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | €57.10 | +0.35% | 254,302 |
| 03/07/26 | €56.90 | -0.87% | 226,428 |
| 02/07/26 | €57.40 | -0.17% | 107,292 |
| 01/07/26 | €57.50 | -0.61% | 74,835 |
| 30/06/26 | €57.85 | -1.45% | 129,596 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions

















